STAGE III PROSTATE ADENOCARCINOMA AJCC V7
Clinical trials for STAGE III PROSTATE ADENOCARCINOMA AJCC V7 explained in plain language.
Never miss a new study
Get alerted when new STAGE III PROSTATE ADENOCARCINOMA AJCC V7 trials appear
Sign up with your email to follow new studies for STAGE III PROSTATE ADENOCARCINOMA AJCC V7, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Short-Course radiation tested to stop prostate Cancer's return
Disease control OngoingThis study is testing a shorter, more targeted form of radiation therapy for men whose prostate cancer was surgically removed but who are at high risk of it coming back. The goal is to see if this precise, 5-session treatment can effectively control the cancer while causing fewer…
Matched conditions: STAGE III PROSTATE ADENOCARCINOMA AJCC V7
Phase: PHASE2 • Sponsor: Jonsson Comprehensive Cancer Center • Aim: Disease control
Last updated Apr 02, 2026 00:26 UTC
-
New hope for men with recurrent prostate cancer: can a drug boost Radiation's punch?
Disease control OngoingThis study is for men whose prostate cancer has returned after surgery. It tests if adding a drug called apalutamide to standard radiation therapy works better than radiation alone to keep the cancer from progressing. Apalutamide works by blocking hormones that can fuel prostate …
Matched conditions: STAGE III PROSTATE ADENOCARCINOMA AJCC V7
Phase: PHASE2 • Sponsor: NRG Oncology • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC